ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » New York » Psychiatry

Top Psychiatry Prescribers in New York

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
ROBERT VINCENT M.D.

Psychiatry

2,300

$335K

61
16 are 65+

85%
patients receiving schedule two controlled substances

Avg: 1%

20%
patients receiving schedule three controlled substances

Avg: 0%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

25%
prescriptions for brand name drugs

Avg: 25%

$146
Average prescription price

Avg: $124

SILVIA HAFLIGER MD

Psychiatry

832

$77K

73
27 are 65+

26%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

34%
prescriptions for brand name drugs

Avg: 25%

$93
Average prescription price

Avg: $124

EMAD SOLIMAN M.D.

Psychiatry

1,717

$492K

260
172 are 65+

13%
patients receiving schedule two controlled substances

Avg: 1%

10%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

37%
prescriptions for brand name drugs

Avg: 25%

$286
Average prescription price

Avg: $124

WILLIAM BELFAR M.D.

Psychiatry

782

$106K

138
23 are 65+

32%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

29%
prescriptions for brand name drugs

Avg: 25%

$136
Average prescription price

Avg: $124

NASRI GHALY MD

Psychiatry

2,821

$352K

222
55 are 65+

18%
patients receiving schedule two controlled substances

Avg: 1%

10%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

29%
prescriptions for brand name drugs

Avg: 25%

$125
Average prescription price

Avg: $124

GREGORY LAVIGNE M.D.

Psychiatry

1,066

$139K

76
32 are 65+

16%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

21%
prescriptions for brand name drugs

Avg: 25%

$131
Average prescription price

Avg: $124

LEON VALBRUN MD

Psychiatry

4,986

$581K

346
166 are 65+

17%
patients receiving schedule two controlled substances

Avg: 1%

3%
patients receiving schedule three controlled substances

Avg: 0%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

25%
prescriptions for brand name drugs

Avg: 25%

$117
Average prescription price

Avg: $124

SARBJOT AJIT M.D.

Psychiatry

997

$127K

97
0 are 65+

28%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

31%
prescriptions for brand name drugs

Avg: 25%

$127
Average prescription price

Avg: $124

AYSAR FATHALLAH-MAMMO MD

Psychiatry

3,330

$161K

85
70 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

25%
prescriptions for brand name drugs

Avg: 25%

$48
Average prescription price

Avg: $124

ARNOLD MANDELSTAM M.D.

Psychiatry

1,331

$181K

104
66 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

18%
prescriptions for brand name drugs

Avg: 25%

$136
Average prescription price

Avg: $124

LEELAND JONES MD

Psychiatry

1,362

$198K

121
28 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

26%
prescriptions for brand name drugs

Avg: 25%

$145
Average prescription price

Avg: $124

SAUNDRA BARNETT-REYES M.D.

Psychiatry

2,841

$474K

135
22 are 65+

13%
patients receiving schedule two controlled substances

Avg: 1%

10%
patients receiving schedule three controlled substances

Avg: 0%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

33%
prescriptions for brand name drugs

Avg: 25%

$167
Average prescription price

Avg: $124

STANLEY GIUDICI M.D., M.A.R.

Psychiatry

3,916

$450K

141
24 are 65+

13%
patients receiving schedule two controlled substances

Avg: 1%

9%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

37%
prescriptions for brand name drugs

Avg: 25%

$115
Average prescription price

Avg: $124

GEORGE FAIREY MD

Psychiatry

3,236

$549K

134
51 are 65+

11%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

38%
prescriptions for brand name drugs

Avg: 25%

$170
Average prescription price

Avg: $124

RONALD ROSEN MD

Psychiatry

6,654

$317K

399
262 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

25%
prescriptions for brand name drugs

Avg: 25%

$48
Average prescription price

Avg: $124

ADOLPH SOTO M.D.

Psychiatry

3,467

$333K

200
74 are 65+

6%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

15%
prescriptions for brand name drugs

Avg: 25%

$96
Average prescription price

Avg: $124

ALEXANDER IVANOV MD

Psychiatry

2,751

$238K

238
157 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

5%
patients receiving schedule three controlled substances

Avg: 0%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

29%
prescriptions for brand name drugs

Avg: 25%

$86
Average prescription price

Avg: $124

BORIS KONNIKOW MD PHD

Psychiatry

2,895

$493K

157
87 are 65+

21%
patients receiving schedule two controlled substances

Avg: 1%

9%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

41%
prescriptions for brand name drugs

Avg: 25%

$170
Average prescription price

Avg: $124

HOWARD GREEN M.D.

Psychiatry

1,871

$156K

202
170 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

14%
prescriptions for brand name drugs

Avg: 25%

$83
Average prescription price

Avg: $124

GIOVANNY NUNEZ M.D.

Psychiatry

7,333

$811K

424
180 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

36%
prescriptions for brand name drugs

Avg: 25%

$111
Average prescription price

Avg: $124

STEVEN NEWMAN M.D.

Psychiatry

6,301

$649K

552
337 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

25%
prescriptions for brand name drugs

Avg: 25%

$103
Average prescription price

Avg: $124

AVRELIYA SHAPIRO M.D.

Psychiatry

727

$101K

38
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

23%
prescriptions for brand name drugs

Avg: 25%

$139
Average prescription price

Avg: $124

LAURA SIRULNIK M.D.

Psychiatry

632

$103K

55
17 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

25%
prescriptions for brand name drugs

Avg: 25%

$164
Average prescription price

Avg: $124

ZINAIDA LYUBOFF MD

Psychiatry

7,112

$754K

351
237 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

40%
prescriptions for brand name drugs

Avg: 25%

$106
Average prescription price

Avg: $124

MEWS ROUSSEAU MD

Psychiatry

1,171

$133K

99
27 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

17%
prescriptions for brand name drugs

Avg: 25%

$114
Average prescription price

Avg: $124

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank